Company
Alphina Therapeutics
At Alphina Therapeutics we are working to fulfill the promise of precision oncology — higher response rates for more patients.
- Status
- Operatingas of 2026-09-19
- Business model
- B2B
- alphinatx.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Alphina Therapeutics is a preclinical stage biotech company that is redefining precision oncology for ADCs with a novel payload.
Funding snapshot
- Total raised
- $40MSum of rounds, as of 2026-09-19Source (opens in a new tab)
- Latest round
- Series A, $40M2021-09
Funding rounds
- Series A
- $40M2021-09, Company stated
Loading relationship preview